|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07F 9/6574 | |
| A61K 31/66 | |||
| A61P 19/08 | |||
| A61P 19/10 |
| (11) | Number of the document | 2493905 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10773501.1 |
| Date of filing the European patent application | 2010-10-26 | |
| (97) | Date of publication of the European application | 2012-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/054124 |
| Date | 2010-10-26 |
| (87) | Number | WO 2011/056589 |
| Date | 2011-05-12 |
| (30) | Number | Date | Country code |
| 254886 P | 2009-10-26 | US |
| (72) |
EBETINO, Frank, Hallock, US
MAZUR, Adam, Wieslaw, US
DOBSON, Roy, Lee, Martin, US
|
| (73) |
Warner Chilcott Company, LLC,
P.O. Box 1005 Union Street Km 1.1 00738-1005, Fajardo,
PR
|
| (54) | BISPHOSPHONATE COMPOUNDS FOR TREATING BONE METABOLISM DISORDERS |
| BISPHOSPHONATE COMPOUNDS FOR TREATING BONE METABOLISM DISORDERS |